1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Community-Acquired Infections Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Community-Acquired Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Community-Acquired Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Community-Acquired Infections 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Community-Acquired Infections Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Panacea Biotec Limited 34
Clinical Trial Overview of Panacea Biotec Limited 34
Daiichi Sankyo Company, Limited 35
Clinical Trial Overview of Daiichi Sankyo Company, Limited 35
Tetraphase Pharmaceuticals Inc. 36
Clinical Trial Overview of Tetraphase Pharmaceuticals Inc. 36
TaiGen Biopharmaceuticals Holdings Limited 37
Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited 37
Janssen Research and Development, LLC 38
Clinical Trial Overview of Janssen Research and Development, LLC 38
Dong Wha Pharma Co., Ltd. 39
Clinical Trial Overview of Dong Wha Pharma Co., Ltd. 39
Cubist Pharmaceuticals, Inc. 40
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 40
Belpharma S.A. 41
Clinical Trial Overview of Belpharma S.A. 41
Clinical Trial Overview of Top Institutes / Government 42
Hanyang University Medical Center 42
Clinical Trial Overview of Hanyang University Medical Center 42
Ewha Womans University 43
Clinical Trial Overview of Ewha Womans University 43
Kyungpook National University 44
Clinical Trial Overview of Kyungpook National University 44
Katholieke Universiteit Leuven 45
Clinical Trial Overview of Katholieke Universiteit Leuven 45
Rennes University Hospital 46
Clinical Trial Overview of Rennes University Hospital 46
University of Milan 47
Clinical Trial Overview of University of Milan 47
Five Key Clinical Profiles 48
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables

Community-Acquired Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Community-Acquired Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community-Acquired Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Community-Acquired Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Community-Acquired Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Community-Acquired Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Community-Acquired Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community-Acquired Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Community-Acquired Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community-Acquired Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community-Acquired Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Community-Acquired Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Community-Acquired Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community-Acquired Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Community-Acquired Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community-Acquired Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Community-Acquired Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2014* 34
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 35
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tetraphase Pharmaceuticals Inc., 2014* 36
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014* 37
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research and Development, LLC, 2014* 38
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Wha Pharma Co., Ltd., 2014* 39
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014* 40
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Belpharma S.A., 2014* 41
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanyang University Medical Center, 2014* 42
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ewha Womans University, 2014* 43
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2014* 44
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014* 45
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014* 46
Community-Acquired Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 47

List of Figures

Community-Acquired Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Community-Acquired Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community-Acquired Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Community-Acquired Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Community-Acquired Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Community-Acquired Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community-Acquired Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community-Acquired Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community-Acquired Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community-Acquired Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Community-Acquired Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Community-Acquired Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community-Acquired Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community-Acquired Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community-Acquired Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Community-Acquired Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community-Acquired Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.